{"id":28489,"date":"2026-03-11T10:43:20","date_gmt":"2026-03-11T10:43:20","guid":{"rendered":"https:\/\/www.medicalbillersandcoders.com\/blog\/?p=28489"},"modified":"2026-05-11T11:04:22","modified_gmt":"2026-05-11T11:04:22","slug":"is-your-medical-billing-company-underperforming","status":"publish","type":"post","link":"https:\/\/www.medicalbillersandcoders.com\/blog\/is-your-medical-billing-company-underperforming\/","title":{"rendered":"Is Your Medical Billing Company Underperforming and Draining Your Revenue?"},"content":{"rendered":"

Yes \u00a0\u2014 <\/strong>if your Net Collection Ratio sits below 92%, your AR over 90 days has crossed the 20% threshold, or your denial rate is climbing past 5%, your medical billing company is underperforming and actively costing your group $150,000 to $400,000 in recoverable revenue every year.<\/p>\r\n

The damage rarely announces itself. Denial rates inch up by fractions of a percent each quarter. Days in AR stretch by two or three days at a time. Monthly reports still arrive on schedule, and claims still get submitted. The dysfunction lives entirely in the delta \u00a0the gap between what your vendor collects and what a specialty-optimized revenue cycle operation is built to protect.<\/p>\r\n

According to the CMS National Health Expenditure Data, U.S. healthcare spending reached $5.3 trillion in 2024<\/strong>, growing 7.2% year-over-year. At that scale, even a 2% efficiency gap in your revenue cycle translates to tens of thousands of dollars written off every month \u00a0silently, and without a single alert from your billing dashboard.<\/p>\r\n

The Triple Threat Quietly Eroding Your Margin<\/h2>\r\n

A medical billing company underperforming at an enterprise level fails across three predictable dimensions. Understanding each one is the first step to quantifying what recovery actually looks like.<\/p>\r\n

1. Payer Contract Leakage<\/h3>\r\n

Most billing vendors submit claims without validating reimbursement against contracted rates at the CPT code level. For a group managing 8-12 active payer contracts and hundreds of procedure codes, underpayments of 3-6% go undetected for months. On a $5M annual billing volume, that’s $150,000-$300,000 in legitimate reimbursement quietly absorbed as “contractual adjustment.”<\/p>\r\n

2. Denial Pattern Blindness<\/h3>\r\n

According to Experian Health’s State of Claims 2025 report, 41% of providers now report that more than 1 in 10 claims is denied<\/strong> up from 30% in 2022. Generic billing services track denial volume. They do not map denial root causes to specific CPT code families, modifier combinations, or payer-specific LCD compliance gaps. Without that mapping, prevention is impossible. Recovery is reactive, and recovery always collects less than prevention would have protected.<\/p>\r\n

3. Aged AR Abandonment<\/h3>\r\n

The industry benchmark for AR over 90 days as a percentage of total receivables is under 20%. When that threshold is breached which it reliably is at a medical billing company underperforming collection probability collapses to 10-15%. Most vendors in this situation begin prioritizing new claim volume over aged AR recovery, effectively abandoning $60,000-$180,000 in legitimate receivables per year.<\/p>\r\n

Revenue Performance Benchmarks: What Acceptable Looks Like vs. What Exceptional Delivers?<\/h2>\r\n

The table below reflects real-world performance differentials across multi-specialty RCM deployments:<\/p>\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n
Revenue Metric<\/strong><\/td>\r\nUnderperforming Vendor<\/strong><\/td>\r\nInternal Team<\/strong><\/td>\r\nMBC RCM Platform<\/strong><\/td>\r\n<\/tr>\r\n<\/thead>\r\n
Net Collection Ratio<\/td>\r\n82-87%<\/td>\r\n84-88%<\/td>\r\n94-98%<\/td>\r\n<\/tr>\r\n
Days in AR<\/td>\r\n45-60+ days<\/td>\r\n40-55 days<\/td>\r\n18-22 days<\/td>\r\n<\/tr>\r\n
First-Pass Denial Rate<\/td>\r\n>8%<\/td>\r\n6-10%<\/td>\r\n<3%<\/td>\r\n<\/tr>\r\n
AR > 90 Days<\/td>\r\n25-35% of AR<\/td>\r\n20-30% of AR<\/td>\r\n<10% of AR<\/td>\r\n<\/tr>\r\n
Denial Root-Cause Reporting<\/td>\r\nMonthly aggregate<\/td>\r\nManual spreadsheet<\/td>\r\nReal-time by payer & CPT<\/td>\r\n<\/tr>\r\n
Reporting Depth<\/td>\r\nBasic statements<\/td>\r\nExcel dashboards<\/td>\r\nCFO-grade KPI dashboard<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n

The NCR differential alone \u00a07 percentage points between an underperforming vendor (87%) and MBC’s medical billing services<\/a> platform (94-98%) \u00a0translates to $700,000 in additional annual collections on a $10M billing volume.<\/strong> That is not an efficiency gain. That is recovered revenue that was always yours.<\/p>\r\n

7 Performance Indicators That Confirm Your Billing Partner Is Failing<\/h2>\r\n

Revenue cycle directors and CFOs at multi-specialty groups should benchmark these seven metrics quarterly:<\/p>\r\n

    \r\n
  1. NCR below 92%<\/strong> \u00a0specialty benchmarks range 94-98%; anything below 92% is recoverable leakage<\/li>\r\n
  2. AR > 90 days exceeding 20%<\/strong> \u00a0collection probability drops to 10-15% past this threshold<\/li>\r\n
  3. First-pass denial rate above 5%<\/strong> \u00a0high-acuity specialties should target sub-3%; above 8% is systemic failure<\/li>\r\n
  4. No payer-level NCR breakdown in monthly reporting<\/strong> \u00a0aggregate statements hide underperforming contracts<\/li>\r\n
  5. Absence of CPT-level denial mapping<\/strong> \u00a0root-cause prevention is impossible without procedure-level analytics<\/li>\r\n
  6. Days in AR above 25<\/strong> \u00a0clean-claim scrubbing infrastructure<\/a> should deliver 18-22 days<\/li>\r\n
  7. Cash-to-net-revenue ratio below 95%<\/strong> \u00a0indicates payment posting errors and chronic underpayment acceptance<\/li>\r\n<\/ol>\r\n

    Any three of these indicators present simultaneously signals structural RCM failure, not a temporary performance variance. The compounding effect at a $5M+ group typically exceeds $300,000 in annual recoverable revenue.<\/p>\r\n

    How to Transition Without Disrupting Active Revenue?<\/h2>\r\n

    The most common objection to switching is operational:<\/strong> what happens to claims in-flight, aged AR, and payer credentialing during the transition? These are legitimate concerns \u00a0and precisely why most groups delay a move that would immediately improve their medical billing services performance<\/a>.<\/p>\r\n

    A structured transition requires four parallel workstreams:<\/strong><\/p>\r\n